Additionally, cathepsin B may play a role in the hyperinflammatory response of COVID-19 [126] and AAT inhibits neutrophil elastase induction of cathepsin B in vivo and in vitro (Figure 2) [127]. This evidence concerns the gene CTSB and COVID-19.